21 casesAmong the 128 cases of non-occupational HIV exposure, 21 were due to occasional unprotected sex.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 20 / 29
21 casesAmong the 128 cases of non-occupational HIV exposure, 21 were due to occasional unprotected sex.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
80 %Approximately 80% of individuals screened during cross-sectional surveys were found to be infected with Plasmodium falciparum.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
14.7 %Among 659 adolescent girls living with HIV in Côte d'Ivoire, 97 (14.7%) received at least one dose of HPV vaccine.
Côte d'Ivoireinfection à HPVHAL · Unilimdocument of 69 observations
24.1 %The overall prevalence of malaria cases detected by RDTs was 24.1% among 9199 participants.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
5 %The prevalence of diabetes mellitus is 5% in Ivory Coast.
Côte d'Ivoirediabète (non précisé)HAL · Unilimdocument of 97 observations
4.5 %Non-typhoidal Salmonella spp. was detected in 4.5% of febrile people in Côte d'Ivoire.
Côte d'IvoireNon-typhoidal Salmonella spp.published 2021Travel medicine and infectious diseasePubMeddocument of 25 observations
27 %S and C genotypes were found in all the regions of Ivory Coast with the highest prevalence in the Northern region (S and C genotypes, 27%).
Côte d'IvoiredrépanocytoseHAL · Unilimdocument of 81 observations
23 %During the post-intervention period, malaria incidence was 23% lower in the LLIN plus larvicide group than in the LLIN-only group.
Côte d'Ivoirepaludismeobserved post-intervention periodHAL · Unilimdocument of 54 observations
10.5 %The prevalence of HIV at baseline was 10.5% among 489 female sex workers enrolled in the PRINCESSE cohort in Côte d'Ivoire.
Côte d'IvoireVIH/sidapublished 2025Frontiers in public healtheurope_pmcdocument of 7 observationsDOI 10.3389/fpubh.2025.1535122
13 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 13% were HBsAg-positive.
Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations
19.7 %At baseline, 19.7% of participants were overweight.
Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations
3.6 aORHIV infection was associated with non-Hodgkin lymphoma (aOR 3.6 [CI 1.9-6.8]).
Côte d'Ivoirenon-Hodgkin lymphoma · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations
0.13 %Triple infection of Plasmodium falciparum, Plasmodium malariae, and Plasmodium ovale accounted for 0.13% of identified Plasmodium species among 2246 positive blood smears.
Côte d'IvoirePlasmodium falciparum + Plasmodium malariae + Plasmodium ovaleHAL · Unilimdocument of 122 observations
82.5 %The proportion of HIV-infected patients reaching CD4+ T cell counts >350/mm³ after six months of ART was 82.5% in the HBV coinfection with high HBV-DNA replication group.
Côte d'IvoireHIV-hepatitis B virus coinfectionpublished 2018AIDS research and human retroviruseseurope_pmcdocument of 4 observations
3 %Eight (3%) of 229 patients in the raltegravir group experienced HIV-associated non-AIDS illnesses.
Côte d'IvoireHIV-associated non-AIDS illnessespublished 2021The Lancet. Infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.1016/s1473-3099(20)30869-0
13.9 %In Survey 1, malaria prevalence was 13.9% among 3052 participants.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
2.9 log10_copies_per_million_PBMCAt baseline, the median HIV-1 DNA was 2.9 log10 copies/million PBMC [IQR 2.5–3.3] in HIV-infected adults in the Temprano trial.
Côte d'IvoireVIH/sidapublished 2020EBioMedicineeurope_pmcdocument of 7 observations
Among the 182 AEB cases, 151 were needlestick injuries, 14 were ocular projections of blood, 12 were cuts, and 5 were mucocutaneous exposures to blood.
Côte d'Ivoireaccidental exposure to bloodobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations
85.3 %Among 659 AGLHIV in Côte d'Ivoire participating in the COVADOCI study, 562 (85.3%) were not vaccinated against HPV.
Côte d'Ivoireinfection à HPVHAL · Unilimdocument of 69 observations
56.5 %The Benin haplotype was detected in 56.5% of the samples.
Côte d'Ivoirehemoglobin disordersHAL · Unilimdocument of 23 observations
34.6 aORHIV infection was associated with Kaposi sarcoma (aOR 34.6 [CI: 17.3-69.0]).
Côte d'Ivoiresarcome de Kaposi · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations
1 patientOne patient underwent surgical arthroplasty.
Côte d'Ivoireavascular osteonecrosis of the femoral headpublished 2009Antiviral therapyeurope_pmcdocument of 11 observations
83.7 %The main symptoms among the eighty patients were headache (83.7%), fever (63.7%), and consciousness disorders (60%).
Côte d'Ivoireméningite cryptococciqueobserved 2005-2008published 2012Medecine et maladies infectieuseseurope_pmcdocument of 11 observations
3.1 %HIV prevalence was 3.1% among inmates screened at the Correctional and Detention Facility of Abidjan.
Côte d'IvoireVIH/sidaobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations
8.6 %Among 879 participants in the Temprano randomized control trial, 76 (8.6%) had hepatitis B surface antigen (HBsAg)-positive with HBV DNA < 2,000 IU/ml.
Côte d'Ivoirehépatite Bobserved 2008 and 2015published 2021Journal of viral hepatitiseurope_pmcdocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.